BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 27599037)

  • 1. MoM cutoffs for variables, an important tool for multivariate analysis and accurate interpretation of preeclampsia risk in high-risk pregnancy at 11-13
    Verma J; Thomas DC; Jhingan G; Puri RD; Verma IC
    Hypertens Pregnancy; 2016 Nov; 35(4):548-558. PubMed ID: 27599037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE.
    Tan MY; Wright D; Syngelaki A; Akolekar R; Cicero S; Janga D; Singh M; Greco E; Wright A; Maclagan K; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):743-750. PubMed ID: 29536574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
    Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia.
    Di Lorenzo G; Ceccarello M; Cecotti V; Ronfani L; Monasta L; Vecchi Brumatti L; Montico M; D'Ottavio G
    Placenta; 2012 Jun; 33(6):495-501. PubMed ID: 22459245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models.
    Murtoniemi K; Villa PM; Matomäki J; Keikkala E; Vuorela P; Hämäläinen E; Kajantie E; Pesonen AK; Räikkönen K; Taipale P; Stenman UH; Laivuori H
    BMC Pregnancy Childbirth; 2018 Jul; 18(1):279. PubMed ID: 29970026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia.
    Huang T; Bedford HM; Rashid S; Rasasakaram E; Priston M; Mak-Tam E; Gibbons C; Meschino WS; Cuckle H; Mei-Dan E
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):190. PubMed ID: 35260099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
    O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competing risk model in screening for preeclampsia by mean arterial pressure and uterine artery pulsatility index at 30-33 weeks' gestation.
    Tayyar A; Garcia-Tizon Larroca S; Poon LC; Wright D; Nicolaides KH
    Fetal Diagn Ther; 2014; 36(1):18-27. PubMed ID: 24970282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of preeclampsia in primigravida in late first trimester using serum placental growth factor alone and by combination model.
    Agarwal R; Chaudhary S; Kar R; Radhakrishnan G; Tandon A
    J Obstet Gynaecol; 2017 Oct; 37(7):877-882. PubMed ID: 28569565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations.
    O'Gorman N; Wright D; Poon LC; Rolnik DL; Syngelaki A; de Alvarado M; Carbone IF; Dutemeyer V; Fiolna M; Frick A; Karagiotis N; Mastrodima S; de Paco Matallana C; Papaioannou G; Pazos A; Plasencia W; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):756-760. PubMed ID: 28295782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of preeclampsia by mean arterial pressure at 11-13 and 20-24 weeks' gestation.
    Gallo D; Poon LC; Fernandez M; Wright D; Nicolaides KH
    Fetal Diagn Ther; 2014; 36(1):28-37. PubMed ID: 24752037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum placental growth factor, pregnancy-associated plasma protein-a and free β-human chorionic gonadotrophin at 30-33 weeks in the prediction of pre-eclampsia.
    Lai J; Pinas A; Poon LC; Agathokleous M; Nicolaides KH
    Fetal Diagn Ther; 2013; 33(3):164-72. PubMed ID: 23445908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks.
    Poon LC; Stratieva V; Piras S; Piri S; Nicolaides KH
    Prenat Diagn; 2010 Mar; 30(3):216-23. PubMed ID: 20108221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
    Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers.
    Litwińska E; Litwińska M; Oszukowski P; Szaflik K; Kaczmarek P
    Adv Clin Exp Med; 2017; 26(3):439-448. PubMed ID: 28791818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-stage screening for preterm preeclampsia at 11-13 weeks' gestation.
    Wright A; Wright D; Syngelaki A; Georgantis A; Nicolaides KH
    Am J Obstet Gynecol; 2019 Feb; 220(2):197.e1-197.e11. PubMed ID: 30414394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired placentation in women with chronic hypertension who develop pre-eclampsia.
    Panaitescu AM; Akolekar R; Kametas N; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):496-500. PubMed ID: 28470791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
    Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH
    Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester prediction of hypertensive disorders in pregnancy.
    Poon LC; Kametas NA; Maiz N; Akolekar R; Nicolaides KH
    Hypertension; 2009 May; 53(5):812-8. PubMed ID: 19273739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.